Construction Plan and time line for The Manufacturing Facilities
-
Gangneung Science and Industrial Complex in Gangwon-do (810-2, Bandong-ri, Sacheon-myeon, Gangneung-si)
1st Plant: Dedicated for Insulin, Insulin Analogs, and other Biosimilars (mAbs)
Insulin, Insulin Glargine, Insulin Lispro, Adalimumab, Bevacizumab
Area
- Land 21325.6 ㎡
Construction Completion Schedule09 / 2023
-
Gangneung Science and Industrial Complex in Gangwon-do(808-17, Bandong-ri, Sacheon-myeon, Gangneung-si)
2nd Plant: Dedicated for Injectable drugs
General Injectables (Liquid; SVP, LVP, Lyophilized)
Area
- Land 30712.9 ㎡
- Building 11848.38 ㎡
Construction Completion Schedule12 / 2023
-
Morgantown, West Virginia, USA.
Dedicated Facility for Insulin & Insulin Analogs
Insulin & Insulin Analogs
Area
- Land 23 Acres ㎡
- Building - ㎡
Construction Completion Schedule12 / 2024